[EN] MONOAMINE OXIDASE INHIBITORS<br/>[FR] INHIBITEURS D'OXYDASE DE MONOAMINE
申请人:US GOV HEALTH & HUMAN SERV
公开号:WO2005007614A1
公开(公告)日:2005-01-27
The invention includes compounds of formula (I), pharmaceutically acceptable salts thereof, compositions containing compounds of formula (I), methods of inhibiting at least one monoamine oxidase using a compound of formula (I), and methods of inhibiting one amine oxidase while inhibiting another amine oxidase to a lesser degree using a compound of formula (I). Wherein each X is independently, an electron donating group, or an electron withdrawing group; n is an integer from 0 to 3 and Y is formula (II), (III), (IV), (V) (VI); wherein E is an electron donating group, and z is an integer from 0 to 3 with the proviso than when Y is formula (VII) or formula (VIII) where the cyclopropyl ring is attached at the carbon substituted with the E, X is not H; or pharmaceutically acceptable salts thereof.
Fluorinated 2-Arylcyclopropan-1-amines – A new class of sigma receptor ligands
作者:Benjamin Schinor、Svenja Hruschka、Constantin G. Daniliuc、Dirk Schepmann、Bernhard Wünsch、Günter Haufe
DOI:10.1016/j.bmc.2020.115726
日期:2020.11
pan-1-amines have been discovered as a newclass of σ receptor ligands showing different selectivity for the two subtypes of the receptor. Generally, compounds substituted in 4-position are much more active than corresponding 3-substituted isomers. trans-2-Fluoro-2-(4-methoxyphenyl)cyclopropan-1-amine (19a) was the most potent (Ki = 4.8 nM) σ1 receptor ligand, while cis-2-fluoro-2-(4-trifluorometh